Literature DB >> 33673825

Bmi-1 alleviates adventitial fibroblast senescence by eliminating ROS in pulmonary hypertension.

Kai Li1, Yan Li2, Youjia Yu1, Jingjing Ding1, Huijie Huang1, Chunyan Chu1, Li Hu1, Yanfang Yu1, Yue Cao1, Peng Xu1, David Fulton3, Feng Chen4,5.   

Abstract

OBJECTIVES: Pulmonary hypertension (PH) is a life-threatening progressive disease with high mortality in the elderly. However, the pathogenesis of PH has not been fully understood and there is no effective therapy to reverse the disease process. This study aims to determine whether cellular senescence is involved in the development of PH.
METHODS: The rat PH model was established by intraperitoneal injection of monocrotaline and evaluated by pulmonary arteriole wall thickness and right ventricular hypertrophy index. Human lung fibroblasts (HLFs) were treated with CoCl2 or hypoxia to induce cellular senescence in vitro. SA-β-gal staining and the changes of senescent markers were used to examine cellular senescence. The molecular mechanism of cellular senescence was further explored by detecting reactive oxygen species (ROS) levels and culturing cells with a conditioned medium.
RESULTS: We revealed the cellular senescence of pulmonary adventitial fibroblasts in vivo in the rat PH model. The expression of Bmi-1, an important regulator of senescence, was decreased in the lungs of PH rats and localized in adventitial fibroblasts. The in vitro experiments showed that p16 expression was increased while Bmi-1 expression was decreased after CoCl2 treatment in HLFs. Mechanistically, Bmi-1 could alleviate CoCl2-induced HLFs senescence by eliminating ROS which further promoted the proliferation of pulmonary artery smooth muscle cells by paracrine mode of action of HLFs.
CONCLUSION: Bmi-1 alleviates the cellular senescence of pulmonary fibroblasts in PH, which expands the pathogenesis of PH and provides a theoretical basis for targeting senescent cells in the treatment of PH.

Entities:  

Keywords:  Bmi-1; Lung fibroblast; Oxidative stress; Pulmonary hypertension; Senescence

Year:  2021        PMID: 33673825      PMCID: PMC7934412          DOI: 10.1186/s12890-021-01439-0

Source DB:  PubMed          Journal:  BMC Pulm Med        ISSN: 1471-2466            Impact factor:   3.317


  48 in total

Review 1.  Definition, clinical classification and initial diagnosis of pulmonary hypertension: Updated recommendations from the Cologne Consensus Conference 2018.

Authors:  Gabor Kovacs; Daniel Dumitrescu; Andreas Barner; Sebastian Greiner; Ekkehard Grünig; Alfred Hager; Thomas Köhler; Rainer Kozlik-Feldmann; Irmtraut Kruck; Astrid E Lammers; Derliz Mereles; Andreas Meyer; Joachim Meyer; Stefan Pabst; Hans-Jürgen Seyfarth; Christoph Sinning; Stephan Sorichter; Gerd Stähler; Heinrike Wilkens; Matthias Held
Journal:  Int J Cardiol       Date:  2018-08-27       Impact factor: 4.164

Review 2.  Cellular senescence: from physiology to pathology.

Authors:  Daniel Muñoz-Espín; Manuel Serrano
Journal:  Nat Rev Mol Cell Biol       Date:  2014-07       Impact factor: 94.444

Review 3.  Definitions and diagnosis of pulmonary hypertension.

Authors:  Marius M Hoeper; Harm Jan Bogaard; Robin Condliffe; Robert Frantz; Dinesh Khanna; Marcin Kurzyna; David Langleben; Alessandra Manes; Toru Satoh; Fernando Torres; Martin R Wilkins; David B Badesch
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

Review 4.  Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors.

Authors:  Judith Campisi
Journal:  Cell       Date:  2005-02-25       Impact factor: 41.582

Review 5.  The Essence of Aging.

Authors:  Jan Vijg; Brian K Kennedy
Journal:  Gerontology       Date:  2015-09-22       Impact factor: 5.140

Review 6.  Cellular Senescence: Aging, Cancer, and Injury.

Authors:  Arianna Calcinotto; Jaskaren Kohli; Elena Zagato; Laura Pellegrini; Marco Demaria; Andrea Alimonti
Journal:  Physiol Rev       Date:  2019-04-01       Impact factor: 37.312

Review 7.  Pulmonary arterial hypertension: pathogenesis and clinical management.

Authors:  Thenappan Thenappan; Mark L Ormiston; John J Ryan; Stephen L Archer
Journal:  BMJ       Date:  2018-03-14

Review 8.  A global view of pulmonary hypertension.

Authors:  Marius M Hoeper; Marc Humbert; Rogerio Souza; Majdy Idrees; Steven M Kawut; Karen Sliwa-Hahnle; Zhi-Cheng Jing; J Simon R Gibbs
Journal:  Lancet Respir Med       Date:  2016-03-12       Impact factor: 30.700

Review 9.  Pulmonary Vascular Diseases in the Elderly.

Authors:  Hooman Poor
Journal:  Clin Geriatr Med       Date:  2017-08-19       Impact factor: 3.076

Review 10.  Cellular senescence and its effector programs.

Authors:  Rafik Salama; Mahito Sadaie; Matthew Hoare; Masashi Narita
Journal:  Genes Dev       Date:  2014-01-15       Impact factor: 11.361

View more
  3 in total

1.  EZH2 Regulates ANXA6 Expression via H3K27me3 and Is Involved in Angiotensin II-Induced Vascular Smooth Muscle Cell Senescence.

Authors:  Yuejin Li; Shikui Guo; Yingpeng Zhao; Rougang Li; Yu Li; Changtao Qiu; Le Xiao; Kunmei Gong
Journal:  Oxid Med Cell Longev       Date:  2022-09-14       Impact factor: 7.310

Review 2.  Important Functions and Molecular Mechanisms of Mitochondrial Redox Signaling in Pulmonary Hypertension.

Authors:  Jorge Reyes-García; Abril Carbajal-García; Annarita Di Mise; Yun-Min Zheng; Xiangdong Wang; Yong-Xiao Wang
Journal:  Antioxidants (Basel)       Date:  2022-02-28

3.  ARID1A knockdown enhances carcinogenesis features and aggressiveness of Caco-2 colon cancer cells: An in vitro cellular mechanism study.

Authors:  Paleerath Peerapen; Kanyarat Sueksakit; Wanida Boonmark; Sunisa Yoodee; Visith Thongboonkerd
Journal:  J Cancer       Date:  2022-01-01       Impact factor: 4.207

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.